184. Incidence and Clinical Outcomes of RSV and Influenza in Solid Organ Transplant Recipients

Abstract Background Solid organ transplant (SOT) recipients are due to their immunosuppressed state susceptible to serious disease caused by respiratory tract infections with influenza or respiratory syncytial virus (RSV). While there is extensive knowledge on influenza among SOT recipients, data on how RSV affect this population remain limited and inconsistent. It is unknown whether severity and outcomes differ between influenza and RSV. Methods All SOT recipients at Copenhagen University Hospital, Denmark, aged >18 years and transplanted in the study period 1st January 2010 to 28th February 2021 were included. The cumulative incidence rate of tests and positive tests were analyzed from date of transplantation until death, re-transplantation, emigration, or end of study. To examine associations between influenza/RSV and mortality we estimated mortality rates (MR) in time periods before infection (including patients who never tested positive), 0-180 days and > 180 after infection. MR ratios were estimated using Poisson regression analyses, adjusted for age, gender, time after transplant, and transplantation type. Results A total of 1862 SOT recipients were included (Table 1), of whom 693 (37.2%) and 202 (10.8%) were tested for influenza and RSV, respectively (Figure 1); test positive rates were 17.7% for influenza and 15,8% for RSV. There was a tendency towards more severe outcomes for lung versus for non-lung SOT recipients in the first 30 days after infection, but most comparisons did not reach statistical significance (Table 2). Influenza and RSV were associated with an approximately 3-5 fold increased mortality the first 6 months following infection (Table 3). Conclusion Testing was more frequent for influenza than RSV, but test-positive rates were similar suggesting underdiagnosis of RSV. Both influenza and RSV were associated with significantly increased mortality the first 6 months following infection. These findings suggest importance of broader testing for RSV and prevention efforts. Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.062
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

184. Incidence and Clinical Outcomes of RSV and Influenza in Solid Organ Transplant Recipients

Vivian Bui Le, Nicolai Aagaard Schultz, Jens Lundgren, Helene Høgsbro Thygesen et al.
Open Forum Infectious Diseases
Respiratory viral infections research
article

184. Incidence and Clinical Outcomes of RSV and Influenza in Solid Organ Transplant Recipients

Vivian Bui Le, Nicolai Aagaard Schultz, Jens Lundgren, Helene Høgsbro Thygesen, Kasper Rossing, Søren Scwartz Sørensen
article en

Abstract

Abstract Background Solid organ transplant (SOT) recipients are due to their immunosuppressed state susceptible to serious disease caused by respiratory tract infections with influenza or respiratory syncytial virus (RSV). While there is extensive knowledge on influenza among SOT recipients, data on how RSV affect this population remain limited and inconsistent. It is unknown whether severity and outcomes differ between influenza and RSV. Methods All SOT recipients at Copenhagen University Hospital, Denmark, aged >18 years and transplanted in the study period 1st January 2010 to 28th February 2021 were included. The cumulative incidence rate of tests and positive tests were analyzed from date of transplantation until death, re-transplantation, emigration, or end of study. To examine associations between influenza/RSV and mortality we estimated mortality rates (MR) in time periods before infection (including patients who never tested positive), 0-180 days and > 180 after infection. MR ratios were estimated using Poisson regression analyses, adjusted for age, gender, time after transplant, and transplantation type. Results A total of 1862 SOT recipients were included (Table 1), of whom 693 (37.2%) and 202 (10.8%) were tested for influenza and RSV, respectively (Figure 1); test positive rates were 17.7% for influenza and 15,8% for RSV. There was a tendency towards more severe outcomes for lung versus for non-lung SOT recipients in the first 30 days after infection, but most comparisons did not reach statistical significance (Table 2). Influenza and RSV were associated with an approximately 3-5 fold increased mortality the first 6 months following infection (Table 3). Conclusion Testing was more frequent for influenza than RSV, but test-positive rates were similar suggesting underdiagnosis of RSV. Both influenza and RSV were associated with significantly increased mortality the first 6 months following infection. These findings suggest importance of broader testing for RSV and prevention efforts. Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 13(Supplement_1)
University of Copenhagen (DK), Copenhagen University Hospital (DK), Rigshospitalet (DK), Centre of Excellence for Health, Immunity and Infections (DK)
Good health and well-being
Openalex Percentile: Top 92%
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.